July 15, 2026
Jaundice — the yellowing of the skin and whites of the eyes from elevated bilirubin — is one of the more alarming visible signs of illness. In India, where hepatitis B and hepatitis A remain prevalent, where fatty liver is extremely common, and where significant alcohol use is widespread, jaundice has a wide differential diagnosis ranging from a self-limiting condition to a life-threatening emergency. Knowing which features of jaundice require urgent medical attention versus monitored outpatient management is clinically important.
Bilirubin is a yellow pigment produced from the breakdown of haemoglobin when old red blood cells are recycled. The liver processes bilirubin, conjugates it, and excretes it in bile — which gives stool its characteristic brown colour. When bilirubin accumulates in the blood — from overproduction, impaired liver processing, or bile duct obstruction — it deposits in tissues, producing the yellow discolouration of jaundice. The pattern of bilirubin elevation (unconjugated, conjugated, or mixed) and the accompanying clinical features distinguish the cause and guide the urgency of response.
Jaundice with fever, rigors, and right upper quadrant pain (Charcot's triad). This combination suggests ascending cholangitis — bacterial infection of the bile ducts — which is a medical emergency requiring urgent hospitalisation, IV antibiotics, and often urgent biliary decompression. Left untreated, ascending cholangitis can progress to sepsis and multi-organ failure within hours to days.
Jaundice with altered mental status or confusion. In the context of liver disease, confusion alongside jaundice suggests hepatic encephalopathy — a serious complication of significant liver failure in which toxins normally cleared by the liver (particularly ammonia) accumulate and impair brain function. Urgent medical evaluation and hospitalisation are required.
Rapidly progressive jaundice over days. Jaundice that deepens rapidly — skin turning progressively yellower over 48 to 72 hours — suggests significant acute liver injury or acute biliary obstruction requiring urgent assessment. This is distinct from the gradual jaundice of chronic liver disease.
Jaundice with dark urine and pale stools simultaneously. This combination — dark (cola-coloured) urine with pale (clay-coloured) stools — indicates obstructive jaundice, in which bile duct obstruction is preventing bilirubin from reaching the intestine (producing pale stools) while conjugated bilirubin spills into urine (dark urine). Obstruction by gallstones, biliary stricture, or — critically — pancreatic or bile duct cancer is the most important concern. Urgent evaluation is required.
Jaundice with vomiting blood or significantly enlarged abdomen. These features suggest advanced liver disease (portal hypertension with oesophageal varices, ascites) and require emergency assessment.
Mild, gradual jaundice in an otherwise well patient — with no fever, no abdominal pain, and no neurological symptoms — is more likely to represent a chronic, stable, or self-limiting cause: Gilbert's syndrome (a benign, hereditary elevation of unconjugated bilirubin that is entirely harmless and requires no treatment); early-stage viral hepatitis (A, B, or E) in a patient who is otherwise managing symptoms; or mild drug-induced liver injury that has been identified and the causative agent stopped. These still warrant clinical assessment — but not emergency attendance. A GP consultation with liver function tests, viral hepatitis serology, and an abdominal ultrasound is the appropriate first-line approach.
Gilbert's syndrome is a common, benign hereditary condition in which unconjugated bilirubin rises during fasting, dehydration, illness, or stress — producing mild, intermittent yellowing of the skin and eyes. It is present in approximately 5–10% of the population. It is entirely benign — it produces no liver damage, no symptoms beyond the yellow discolouration during triggers, and requires no treatment. It is worth knowing about because it can be alarming when first noticed, particularly during or after illness when bilirubin tends to rise.
In the early to moderate stages of fatty liver (MASLD), jaundice is not a feature. Jaundice appears in the context of advanced liver failure (cirrhosis) or acute decompensation. A patient with Grade 1 or 2 fatty liver who develops jaundice should be investigated for other causes — hepatitis, bile duct obstruction, medication reactions — rather than attributing it to the fatty liver. Read our liver health pillar: liver health and fatty liver.
Same-day emergency evaluation for: jaundice with fever, confusion, rapidly worsening over days, dark urine with pale stools, or abdominal pain. Within 24 to 48 hours for: new-onset jaundice without the alarming features above, in a patient who is otherwise well. Within one week for: previously investigated mild jaundice with a known benign cause (Gilbert's syndrome) that has recurred under a typical trigger (illness, fasting). When uncertain — err toward faster evaluation.
ALIV's liver support IV is not appropriate for acute jaundice of unknown cause — the clinical investigation and management of the underlying cause takes priority over supportive IV therapy. Once the cause of jaundice has been identified and appropriately managed (for example, hepatitis A recovery or post-cholestatic recovery after bile duct clearance), supportive liver IV therapy may have a role in the convalescent phase — but this is a decision made with the treating specialist.
Physiological neonatal jaundice — which affects the majority of newborns in the first week of life — is a normal part of the transition from foetal to neonatal haemoglobin and is managed with phototherapy when bilirubin reaches certain thresholds. It is a different entity from adult jaundice and is managed by paediatric/neonatal specialists. This article addresses adult jaundice only.